As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >


Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >


Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >


5 Avenue du Général de Gaulle
94160 Saint-Mandé – France

CEO: Alexandros Pantalis
CSO: Adèle James
Web Site >
Phagos - Genopole's Company Phagos - Genopole's Company

Logo Gene.iO small#Ag Tech & Green Tech

  • BioTech
  • DeepTech
  • CleanTech
  • AgriTech

Field of Activity

Phagos is developing the use of bacteriophages, a bacterial virus, for controlling infectious diseases in aquaculture.


Phagos is built upon a shared ideal: the use of entrepreneurship as an accelerator of positive impacts. Thereto, Adèle James, PhD in molecular microbiology,and Alexandros Pantalis, serial tech entrepreneur, are working to bring sustainable solutions to the fight against antibiotic resistance.


Bacteriophages are the deadliest entities on earth. They cause billions of deaths every day—luckily only among bacteria! At Phagos, we are harnessing their exceptional potential. By optimizing bacteriophage populations, we contribute to the control of pathogenic bacteria.


Phagos was chosen by Entrepreneur First for pre-seed investment and by Wilco for its Cleantech & Agritech program.
We have demonstrated in vitro efficacy for our bacteriophages and our test results in vivo show a clear reduction in animal mortality.
We are thus preparing a seed funding campaign.


Phagos is seeking partnerships with research labs, aquaculture and animal health actors, commercial networks in Asia, and biotech investors for seed funding.

  • Further Information

    2 cofounders
    6 staff members

    STRENGTHS: Demonstration of sustainable efficacy for natural methods of infectious diseases control. Development of a novel approach to infectious diseases, potentially able to bring change to modern medicine.

    INNOVATION ASSETS: Bacteriophages show great promise in a diverse range of fields and yet their use remains experimental. We hope to give wings to their potential.

    OTHER FACTS: If solutions for it are not found, antibiotic resistance could cause more deaths than cancer by 2050. Bacteriophages are particularly promising for that quest.

    Citation“Resistance to antibiotics could cause more deaths than cancer by 2050. In order to avoid this mounting crisis, it is urgent to develop alternatives such as phage therapy”


Genopole’s Companies

#Ag Tech & Green Tech

In the same field


DNTech’s technology offers detection of microorganisms in less than an hour.


The VERY Food Co

Activity of research, sale, production, distribution and marketing of all unregulated food and agri-food products.

SafeInsight - Entreprise génopolitaine


SafeInsight seeks to provide a response to the growing concerns of consumers for the composition of the products they buy and accompanies manufacturers aiming to attentively circumscribe the problem of endocrine disruptors.

Nutropy - Genopole's company


Nutropy develops gourmet French cheese alternatives that are more sustainable and better for our health and animal welfare.

Biomédé - Genopole's company


BIOMEDE selects and markets seeds for "hyperaccumulator" plants, i.e., those capable of taking up large amounts of trace metals from the soil.

nextProtein - Genopole's company


The French start-up nextProtein uses black soldier fly larvae to convert food & agriculture by-products into ingredients for animal feed with the objective of accelerating the advent of sustainable agriculture.

Altar - entreprise génopolitaine


Altar is a specialist in the conception and operation of automated fluidic continuous culture systems for adaptive laboratory evolution and the development of microbial strains for industry.

Ynsect - Genopole's company


Ÿnsect, a pioneering company in the "insect" industry, is breeding and processing insects thanks to its large-scale production and processing technologies to provide high quality and value-added products, particularly for pets, fish of aquaculture, plants and human nutrition.

Global Bioenergies - entreprise génopolitaine - logo 2022

Global Bioenergies

Global Bioenergies is developing a process to convert renewable resources into hydrocarbons through fermentation.

EvalDépol - Genopole's company


EvalDepol provides services and laboratory tests for soil remediation and water and air treatment.

Anova Plus - Genopole's Company


Anova-Plus develops in-the- eld DNA/RNA testing toolkits for the rapid detection of plant pathogens and pesticide-resistant organisms. These toolkits are branded under Flashdiag® and intended for the agriculture, food production and environmental sectors.

Algentech Plant Gene Technologies - Genopole's company


Green factories for specialty ingredient production in plant cells. Synthetic biology, enzymes and proteins production for organelles.

agdia EMEA - entreprise génopolitaine Evry

Agdia EMEA

Leading the way to healthy crops. Agdia-EMEA provides diagnostic solutions based on immunological and molecular technologies for plant pathogens and GMOs. Our mission is to help the different players of the agricultural industry to obtain high quality productions by providing them with reliable diagnostic tools and high level services.

Algama - Genopole's Company


Société agroalimentaire qui invente des produits alimentaires du quotidien en exploitant le potentiel unique des microalgues. Les produits réalisés sont plus sains, plus respectueux de l'environnement sans compromis sur le goût.

View all >
With the support from